Clarivate’s recent contract wins put AI capabilities in focus
Clarivate (CLVT) has just been selected to power AI assisted image search for the U.S. Patent and Trademark Office and to modernize France’s national academic library system, drawing investor attention to its core data and software offerings.
See our latest analysis for Clarivate.
Despite recent contract wins, Clarivate’s share price has been under pressure, with a 30 day share price return of 4.23% lower, a year to date share price return down 37.04%, and a 1 year total shareholder return down 52.11%. This suggests sentiment has weakened over time even as interest in its AI offerings is rising.
If Clarivate’s AI contracts have caught your attention, it may be worth seeing what else is happening across the sector by checking out 34 AI small caps.
Clarivate’s shares have fallen hard while analyst targets and intrinsic value estimates sit higher, leaving a wide gap between recent price and implied worth. How does that spread frame where fair value might reasonably sit?
Most Popular Narrative: 51.5% Undervalued
Clarivate closed at $2.04, while the most followed narrative on the stock suggests fair value closer to $4.21, creating a sizable valuation gap for investors to weigh.
Clarivate operates behind the scenes, but its influence shapes outcomes across innovation, law, and research. Intellectual property has become too important to manage informally. Data-driven insight is now a requirement, not a luxury.
Want to see what sits behind that number for Clarivate? The narrative leans heavily on long run revenue potential, margin lift and a richer future earnings multiple. Curious which specific assumptions support that jump in fair value and how they interact?
Result: Fair Value of $4.21 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Clarivate’s annual revenue contraction and reported net loss of $137.4 million highlight execution and profitability risks that could challenge the undervalued narrative.
Find out about the key risks to this Clarivate narrative.
Next Steps
Given the mixed tone around Clarivate’s contracts, valuation gap and recent losses, it may be useful to move quickly and review the full picture for yourself by checking 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Clarivate?
Clarivate’s story is only one angle. If you stop here, you could miss other stocks with different strengths, risk profiles and income potential highlighted by the Simply Wall St Screener.
- Target potential mispricings by scanning for companies that combine strong fundamentals with lower valuations using the 50 high quality undervalued stocks.
- Build a steadier income stream by focusing on established payers through the 9 dividend fortresses.
- Prioritise resilience by hunting for companies with stronger financial footing via the solid balance sheet and fundamentals stocks screener (49 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com